Skip to content

Study on the correlation between epicardial fat volume and dampness syndrome in traditional Chinese medicine in patients with coronary heart disease based on deep learning technology and radiomics

Study on the correlation between epicardial fat volume and dampness syndrome in traditional Chinese medicine in patients with coronary heart disease based on deep learning technology and radiomics

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400079869
Enrollment
Unknown
Registered
2024-01-15
Start date
2022-07-11
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease

Interventions

Coronary heart disease dampness syndrome group:NA
Coronary heart disease non-dampness syndrome group:NA

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria for coronary heart disease: ? Coronary CTA confirms the degree of vascular stenosis =50% ?Age 18 to 80 years old ?Sign the informed consent form (2) Meet the diagnostic criteria for dampness syndrome in traditional Chinese medicine Refer to the "Clinical Diagnostic Criteria for Phlegm-Dampness Syndrome in Coronary Heart Disease" (Hu Jingqing, Xu Weiming, Wang Chuanchi, et al. Interpretation of the Clinical Diagnostic Criteria for Phlegm-Dampness Syndrome in Coronary Heart Disease [J]. Chinese Journal of Basic Medicine of Traditional Chinese Medicine, 2017, 023(009):1247-1250. ) Develop a TCM symptom evaluation scale. During the collection of patient clinical data, two experts with associate senior professional titles or above will conduct dialectical identification of patient data that are difficult to identify.

Exclusion criteria

Exclusion criteria: (1) Severe liver, kidney, and heart dysfunction (2) Any other serious disease or condition such as: malignant tumor, severe uncontrolled hypertension, diabetes, arrhythmia (3) Participated in another clinical study within 30 days before enrollment or received randomization in this study (4) Pregnant women, women preparing to become pregnant and lactating women (5) Patients allergic to iodinated contrast media (6) Patients who are judged by the researcher to be unfit to participate in this study

Design outcomes

Primary

MeasureTime frame
Epicardial adipose tissue volume;Pericoronary adipose tissue;Traditional Chinese Medicine Phlegm-Dampness Syndrome Score;

Secondary

MeasureTime frame
age;blood pressure;HbA1c;HDL-C;coronary artery calcium score;degree of coronary artery stenosis;heart rate;EF;MONO;CAD-RAD degree;

Countries

China

Contacts

Public ContactLei Wang

Guangdong Provincial Hospital of Chinese Medicine

Dr.wanglei@gzucm.edu.cn+86 137 2407 8381

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026